Drug recall · February 10, 2016
Lyrica (pregabalin) capsules recall
Why: FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
- Lots / codes
Lot #: M07862, Exp 05/2018; M07865, Exp 06/2018
- Quantity
- 116,400 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide and Puerto Rico
- Initiated
- January 11, 2016 · Voluntary: Firm initiated
- Classified
- February 1, 2016
- Reported
- February 10, 2016
- Ended
- April 24, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lyrica
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.